BAX 855: Clinical Trials

1 trial of BAX 855, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1
Phase 31Completed 1

Follow BAX 855: new trials by email Literature Review of BAX 855 trials Research Report on BAX 855

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study Investigating a PEGylated Recombinant Factor VIII (BAX 855) for Hemophilia A (PROLONG-ATE Study)
Antihemophilic Factor (Recombinant) - Plasma/Albumin Free Method, PEGylated Recombinant Factor VIII - Hemophilia A
Phase 2 / Phase 3CompletedBaxalta now part of Shire1592013-01-312021-05-20

Conditions studied

Hemophilia A (1)

Sponsors

Baxalta now part of Shire (1)

Countries

Australia (1)  ·  Austria (1)  ·  Bulgaria (1)  ·  Czechia (1)  ·  Germany (1)  ·  Israel (1)  ·  Japan (1)  ·  Lithuania (1)  ·  Malaysia (1)  ·  Netherlands (1)  ·  Poland (1)  ·  Romania (1)  ·  South Korea (1)  ·  Spain (1)  ·  Sweden (1)

Results publications

PMID 26157075